Isotretinoin Clinical Trials

• Vitamin E in Preventing the Side Effects of Isotretinoin in Former and Current Smokers Who Are Receiving Isotretinoin to Prevent Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003599 - Active, not recruiting
  Lung Cancer; prevention of lung cancer
  
• Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
  ClinicalTrials.gov Identifier: NCT00014729 - Active, not recruiting
  Epidermolysis Bullosa
  
• MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00098891 - Active, not recruiting
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• Interferon alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062010 - Active, not recruiting
  Recurrent Small Cell Lung Cancer
  
• Isotretinoin With or Without Vitamin E for Prevention of Lung Cancer
  ClinicalTrials.gov Identifier: NCT00002586 - Active, not recruiting
  Non-small cell lung cancer; Small Cell Lung Cancer; Drug Toxicity
  
• Interferon alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00002737 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer; Renal Cell Adenocarcinoma
  
• Isotretinoin, Interferon alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00054561 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
  ClinicalTrials.gov Identifier: NCT00003564 - Active, not recruiting
  adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; recurrent adult brain tumor; Mixed Gliomas
  
• Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00112502 - Recruiting
  adult giant cell glioblastoma; adult gliosarcoma; adult glioblastoma
  
• Isotretinoin, Interferon Alfa-2b, and Paclitaxel in Treating Patients With Stage IV, Recurrent, or Persistent Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00138151 - Recruiting
  recurrent cervical cancer; stage IVB cervical cancer
  
• Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00021359 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00176527 - Active, not recruiting
  Prostate Cancer
  
• Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00002506 - Active, not recruiting
  recurrent non-small cell lung cancer; recurrent cervical cancer; recurrent squamous cell carcinoma of the lip and oral cavity; ...
  
• Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00026312 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized resectable neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00499616 - Recruiting
  Neuroblastoma
  
• Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00526318 - Recruiting
  Neuroblastoma
  
• PXD101 and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00334789 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00030719 - Recruiting
  regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma
  
• Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme (GBM)
  ClinicalTrials.gov Identifier: NCT00555399 - Recruiting
  Glioblastoma Multiforme; Anaplastic Glioma
  
• Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors
  ClinicalTrials.gov Identifier: NCT00001073 - Completed
  HIV Infections; Cervix, Dysplasia
  
• Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00324740 - Recruiting
  Kidney Cancer
  
• Study of Isotretinoin for the Prevention of Skin Cancer in Patients With Xeroderma Pigmentosum or Nevoid Basal Cell Carcinoma Syndrome
  ClinicalTrials.gov Identifier: NCT00025012 - Completed
  prevention of skin cancer
  
• Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
  ClinicalTrials.gov Identifier: NCT00217412 - Recruiting
  Brain and Central Nervous System Tumors; Leukemia; Lymphoma; Unspecified Childhood Solid Tumor, Protocol Specific
  
• Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003585 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00004110 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Multiple Therapies in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00040872 - Active, not recruiting
  regional neuroblastoma; disseminated neuroblastoma; recurrent neuroblastoma; localized unresectable neuroblastoma
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003405 - Active, not recruiting
  untreated adult acute myeloid leukemia; childhood acute megakaryocytic leukemia (M7); adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003619 - Completed
  Polycythemia Vera; Thrombocytopenia; Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; ...
  
• High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
  ClinicalTrials.gov Identifier: NCT00078988 - Completed
  high-grade childhood cerebral astrocytoma; recurrent childhood cerebellar astrocytoma; recurrent childhood cerebral astrocytoma
  
• Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
  ClinicalTrials.gov Identifier: NCT00000764 - Completed
  HIV Infections; Anus Neoplasms
  
• Use of Isotretinoin for Prevention of Skin Cancer in Patients with Xeroderma Pigmentosum or Nevoid Basal Cell Carcinoma Syndrome
  ClinicalTrials.gov Identifier: NCT00005661 - Completed
  Basal Cell Nevus Syndrome; Xeroderma Pigmentosum
  
• Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplantation in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00025038 - Completed
  juvenile myelomonocytic leukemia
  
• Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00089258 - Completed
  localized unresectable neuroblastoma; disseminated neuroblastoma; regional neuroblastoma; stage 4S neuroblastoma; recurrent neuroblastoma
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00017368 - Completed
  regional neuroblastoma; disseminated neuroblastoma; localized unresectable neuroblastoma; stage 4S neuroblastoma
  
• Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00005576 - Completed
  disseminated neuroblastoma; regional neuroblastoma; recurrent neuroblastoma
  
• Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00070200 - Completed
  recurrent neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma; localized resectable neuroblastoma; regional neuroblastoma; ...
  
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00004188 - Completed
  localized resectable neuroblastoma; regional neuroblastoma; disseminated neuroblastoma; stage 4S neuroblastoma; localized unresectable neuroblastoma